- The new funds will support the company’s expansion into Latin America, the development of advanced software for doctors and marketing and sales activities in core markets
- London-based One Peak Partners joins existing investors Target Global and ENERN Investments in the round
- This round brings total raised by DocPlanner to approximately €46 million
Healthcare booking platform DocPlanner has today announced the closing of a €15 million Series D financing round, just ten months after announcing a Series C round of $20 million and successfully merging with Spanish healthcare platform Doctoralia. This brings the total raised by DocPlanner to approximately €46 million, and further marks the company’s progress to become the leading healthcare platform globally.
The new round is led by existing shareholder ENERN Investments; Target Global, another existing investor, and London-based One Peak Partners round out the syndicate. The investment will be used to fund new offices in Brazil and Mexico over the next six months as well as marketing and sales in DocPlanner’s core markets in Southern Europe and Latin America.
The Poland-based company is also actively expanding its SaaS capabilities with the aim of providing more advanced solutions to doctor practices. The company has not ruled out bolt-on acquisitions of young, innovative cloud-based software companies to accelerate this process.
MariuszGralewski, founder and CEO of DocPlanner, said:
“We continue the process of integrating the DocPlanner and Doctoralia teams and have already developed a very coherent and well-functioning organisation with a common mission and strategy. We have been able to take the best practices and capabilities from each business to create something that is way beyond the sum of its parts.”
“In addition to consolidating our presence in core markets, our goal with the new funding is to expand our offering to doctors by moving beyond the calendar management. This will also help us accomplish our global mission to ‘make the healthcare experience more human’.”
Pavel Mucha, Partner at ENERN Investments commented:
“We believe the time has come for uprising SaaS technologies to change the way we interact with doctors and manage our health, which will greatly advance the quality of life around the world. DocPlanner can make a global dent.”
Humbert de Liedekerke, Managing Partner of One Peak Partners added:
“Behind the success of DocPlanner lies the ambition to help millions of patients make better healthcare decisions. We look forward to building on the considerable success already achieved by management and supporting the company in creating a category-defining, global leader.”